Mar 31, 2026
This week’s edition of JACC This Week brings Dr. Carolyn Lam and Dr. Harlan Krumholz into a deep exploration of a special issue devoted to innovative cardiovascular research emerging from China. As they highlight newly published studies and their global significance, they reflect on how scientific progress...
Mar 24, 2026
Drs. Carolyn Lam and Harlan Krumholz unpack new JACC research on cardiometabolic health, highlighting how COVID‑19 shaped cardiovascular care, mortality patterns, and disparities. They also break down updated evidence on PREVENT risk equations in young adults, gaps in lipid testing and statin use, and what...
Mar 17, 2026
In this episode, Dr. Carolyn Lam and Dr. Harlan Krumholz break down key studies from this week’s JACC issue, including new evidence on Chagas‑related heart failure, updated diastolic function guidelines, and the connection between cardiomyopathy gene variants and atrial fibrillation. They also discuss findings...
Mar 10, 2026
Dr. Carolyn Lam and Dr. Harlan Krumholz sit down with Dr. Rishi Wadhera to unpack the first-ever JACC Cardiovascular Statistics issue. They explore why this annual report matters, the key trends in U.S. cardiovascular health, and what clinicians should take away about hypertension, diabetes, obesity, and heart‑failure...
Mar 3, 2026
In this episode of JACC This Week, Dr. Carolyn Lam and Dr.
Harlan Krumholz spotlight a mini-focus issue on hypertrophic
cardiomyopathy (HCM), a field undergoing rapid transformation.
The discussion centers on the MAPLE-HCM trial comparing aficamten
and metoprolol in symptomatic obstructive HCM, highlighting
multidomain...